Nafamostat Mesylate Improved Survival Outcomes of Sepsis Patients Who Underwent Blood Purification: A Nationwide Registry Study in Japan

Nafamostat mesylate (NM) is a synthetic serine protease inhibitor that can be used as an anticoagulant during blood purification in critically ill patients, as well as a treatment for disseminated intravascular coagulation. Although NM has been reported to reduce the risk of bleeding during blood pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamijo, Hiroshi, Mochizuki, Katsunori, Nakamura, Yuta, Mori, Kotaro, Ichikawa, Michitaro, Nitta, Kenichi, Imamura, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464767/
https://www.ncbi.nlm.nih.gov/pubmed/32823637
http://dx.doi.org/10.3390/jcm9082629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464767/
https://www.ncbi.nlm.nih.gov/pubmed/32823637
http://dx.doi.org/10.3390/jcm9082629

Ejemplares similares